Cervical Cancer

Cat 1 · 30 days

appointment within 30 calendar days. - Patients with early stage or locally advanced Cervical cancer should be referred to the Gynaecology-Oncology surgical team for evaluation and further investigation / staging. Patients are usually then presented in a multi-disciplinary meeting for treatment planning and further referral if required for Medical Oncology input - Women with a positive oncogenic HPV (16/18) test result should be referred directly for colposcopic assessment, informed by the result of the reflex liquid-based cytology. Women with a positive oncogenic HPV (not 16/18) test result with a reflex liquid-based cytology result of possible high-grade lesion or high-grade lesion should be referred directly for colposcopic assessment through the Gynaecology team initially and then will be referred further to the Gynaecology-Oncology MDT as appropriate - Patients requiring chemotherapy and radiation for locally advanced disease (previously biopsy confirmed and discussed in Gynae-Oncology MDT) For optimum care, patient should be seen within 2 weeks - Patients requiring adjuvant chemotherapy (biopsy confirmed) For optimum care, patient should be seen within 2 weeks - Metastatic cervical cancer (biopsy confirmed

Cat 2 · 90 days

appointment within 90 calendar days. - Patients with previously treated locally advanced cervical cancer that required chemotherapy and require routine follow-up - Transfer of care from another health service

Cat 3 · 365 days

appointment within 365 calendar days. - No category 3 criteria